[Recombinant adenovirus Ad-APN-EGFP constructing and promoting osteogenesis around implants]
Summary
A novel recombinant adenovirus, Ad-APN-EGFP, successfully enhanced bone formation around implants. This adenovirus efficiently transfected rat bone marrow stem cells, promoting significant osteogenesis in vivo.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Biomaterials Science
Background:
- Adiponectin (APN) plays a crucial role in bone metabolism and osteogenesis.
- Gene delivery systems are essential for targeted therapeutic protein expression.
- Improving osseointegration of implants is critical for successful orthopedic and dental applications.
Purpose of the Study:
- To construct a recombinant adenovirus vector, Ad-APN-EGFP, carrying the adiponectin gene.
- To evaluate the transfection efficiency of Ad-APN-EGFP in rat bone marrow stem cells (BMSCs).
- To assess the efficacy of Ad-APN-EGFP in promoting osteogenesis around hydroxyapatite (HA)-coated implants in a rat model.
Main Methods:
- Ad-APN-EGFP was constructed and verified using DNA sequencing and restriction enzyme digestion.
- In vitro transfection of BMSCs with Ad-APN-EGFP was performed, followed by assessment of transfection efficiency and APN mRNA expression.
- An in vivo study involved implanting HA-coated implants in rat femoral defects and administering Ad-APN-EGFP or phosphate-buffered saline (PBS) to experimental and control groups, respectively.
- Osteogenesis around implants was evaluated four weeks post-implantation using hematoxylin-eosin staining.
Main Results:
- Successful construction and verification of the Ad-APN-EGFP recombinant adenovirus.
- High transfection efficiency (≥ 90%) of Ad-APN-EGFP in BMSCs.
- Significantly higher APN mRNA expression in Ad-APN-EGFP transfected BMSCs compared to controls.
- More evident osteogenesis around implants in the experimental group treated with Ad-APN-EGFP compared to the control group.
Conclusions:
- Ad-APN-EGFP can be effectively transfected into BMSCs, leading to high-level APN mRNA expression.
- The Ad-APN-EGFP adenovirus demonstrates a significant capacity to enhance osteogenesis around implants in vivo.
- This study highlights the potential of Ad-APN-EGFP as a therapeutic agent for improving bone regeneration and implant osseointegration.
